Synthetica AS
CUSTOM SYNTHESIS & CONTRACT RESEARCH
Export Market
Africa
Asia
Denmark
Europe
North America
Oceania
South America
South Asia
Sweden
West Asia
Additional Information
Finance
Total revenues:
24.662
Operating profit: -1.263
Operating profit before tax:
-1.477
Total assets: 6.939
Total equity: 356
Currency: NOK (all numbers in thousands)
Management
Board Chairman:
Egil Greve
Board Members:
Inger Reidun F Aukrust
Kai Schröder
General Manager:
Inger Reidun F Aukrust
Subsidiary companies:
Largest shareholders:
N/A
KEYWORDS
Biotechnology, Health Care, Research and experimental development services,